This application-based continuing pharmacy education course will provide a “journal club format” discussion for pharmacists, student pharmacists, and residents to review the 2018 Clostridium difficile guidelines and a trial that brings to light a newer C. difficile therapeutic agent not discussed in the guidelines. Join us to discuss the new recommendations for treatment of Clostridium difficile and the potential place in therapy for this new agent.
At CEimpact, we believe pharmacy teams enhance the health and wellness of patients and communities. We create continuing education that develops and inspires pharmacists and technicians throughout their careers.
This post is related to:
Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.
